Clinical Trials on Glabellar Crease in Australia
Total 612 results
-
BioNTech SEBristol-Myers SquibbRecruitingBreast NeoplasmsUnited States, Australia, China, Japan, Italy, Spain, United Kingdom, Belgium, Poland, Georgia, South Korea, Czechia, Germany
-
ETOP IBCSG Partners FoundationNational Cancer Institute (NCI); Breast International GroupCompletedBreast CancerUnited States, Australia, Switzerland, Italy, Canada, Belgium, Peru, United Kingdom, Egypt, New Zealand, Slovenia, South Africa, Hungary, India, Germany, Sweden, Brazil
-
Hoffmann-La RocheCompletedBreast CancerSpain, Russian Federation, Austria, Italy, Germany, Portugal
-
Hoffmann-La RocheCompletedEarly Breast CancerSpain, Korea, Republic of, Australia, Taiwan, Ukraine, Poland, Russian Federation, United States, Germany, Brazil, Hungary
-
Queen Mary University of LondonCancer Research UKCompletedBreast CancerFrance, Switzerland, Ireland, United Kingdom, Italy, Australia, Austria, Belgium, Chile, Germany, Hungary, Malta, Sweden, Turkey
-
Queen Mary University of LondonCompletedBreast CancerIreland, United Kingdom, Switzerland, Australia, Belgium, Chile, Denmark, Finland, Germany, Hungary, Italy, Malta, Portugal, Turkey
-
AstraZenecaCompleted
-
PfizerTerminatedBreast NeoplasmsAustralia, Canada, Bulgaria, Spain, Germany, Italy, Korea, Republic of, Turkey, Brazil, Colombia, Taiwan, Philippines, Singapore, Mexico, United Kingdom, Hong Kong, India, South Africa, Japan, France, Argentina, Chile, Peru
-
G1 Therapeutics, Inc.CompletedBreast Cancer | TNBC - Triple-Negative Breast CancerUnited States, Spain, China, France, Australia, Georgia, Poland, Bulgaria, Moldova, Republic of, Russian Federation, Ukraine
-
Hoffmann-La RocheCompletedTriple Negative Breast CancerUnited States, Korea, Republic of, Belgium, Canada, Germany, United Kingdom, Argentina, Australia, Brazil, Finland, France, Greece, Hungary, Poland, Slovenia, Spain, Taiwan, Turkey, Japan, Singapore, Colombia, Bosnia and Herzegovina, Guatema... and more
-
European Organisation for Research and Treatment...CompletedBreast CancerFrance, Thailand, Australia, Belgium, Netherlands, Slovenia, United Kingdom, Malaysia, Poland, Russian Federation, Philippines, Taiwan
-
Nektar TherapeuticsCompletedBreast Cancer | MetastasisUnited States, Australia, Belgium, Canada, France, Israel, Italy, Portugal, Spain, United Kingdom
-
AbbVieNSABP Foundation Inc; German Breast Group; US Oncology Research; Grupo Espanol...CompletedTriple Negative Breast CancerUnited States, Australia, Belgium, Canada, Czechia, France, Germany, Hungary, Italy, Korea, Republic of, Netherlands, Russian Federation, Spain, Taiwan, United Kingdom
-
Hoffmann-La RocheTerminatedMetastatic Breast CancerSpain, Korea, Republic of, China, Croatia, Italy, Colombia, Finland, United Kingdom, United States, Canada, Philippines, Australia, Norway, France, Poland, Turkey, Russian Federation, Brazil, Portugal
-
ETOP IBCSG Partners FoundationPfizerActive, not recruitingBreast Cancer RecurrentFrance, Italy, Spain, Switzerland, Hungary, Austria
-
Genentech, Inc.CompletedBreast CancerBelgium, Israel, United States, Spain, Denmark, Germany, Hong Kong, Russian Federation, Australia, New Zealand, Korea, Republic of, Malaysia, Singapore, Italy, Czech Republic, France, Peru, Canada, United Kingdom, Chile, Thailand, Argentin... and more
-
MedSIRRecruitingAdvanced Breast Cancer | Hormone Receptor Positive Breast Carcinoma | Advanced Breast CarcinomaSpain, France, Italy, Germany, Austria, Belgium, United Kingdom, Portugal, Poland
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)TerminatedPain | Breast Cancer | Prostate CancerUnited States, Australia, Peru, Puerto Rico
-
AbbVieCompletedMetastatic Breast CancerUnited States, Argentina, Australia, Austria, Belarus, Belgium, Canada, Chile, Colombia, Czechia, Denmark, Estonia, Finland, France, Germany, Hungary, Israel, Italy, Korea, Republic of, Latvia, Lithuania, Mexico, Netherlands, Norway, Po... and more
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited States, Australia, Canada, Germany, Argentina, Poland, Russian Federation, Belgium, Spain, Latvia, Netherlands, New Zealand, Mexico, Pakistan, Italy, Austria, Chile, Peru, South Africa, Czech Republic, Hungary, Korea, Republic... and more
-
Hoffmann-La RocheCompletedBreast CancerItaly, Belgium, Canada, United Kingdom, Argentina, Australia, Austria, Brazil, Bulgaria, China, Croatia, Denmark, Dominican Republic, Ecuador, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, Indonesia, Irelan... and more
-
Baxter Healthcare CorporationCompletedBreast Cancer | Lumpectomy | Mastectomy Plus Axillary Lymph Node Dissection | Lymphatic LeakageGermany, Austria, France, Italy
-
Central European Cooperative Oncology GroupCompletedMetastatic Breast CancerSerbia, Israel, Croatia, Hungary, Poland, Bosnia and Herzegovina, Latvia, Slovakia, Austria, Czechia, Bulgaria, Romania
-
Novartis PharmaceuticalsNCIC Clinical Trials GroupCompletedBreast CancerUnited States, Belgium, Canada, United Kingdom, Argentina, Australia, France, Germany, Israel, Italy, Japan, Netherlands, Poland, Russian Federation, Spain, Taiwan, Thailand, India, Korea, Republic of, Mexico, Ukraine
-
Hoffmann-La RocheCompletedBreast CancerUnited States, Korea, Republic of, Canada, United Kingdom, Australia, Belgium, Brazil, France, Slovenia, Spain, Taiwan, Japan, Italy, Argentina, India, Germany, Hungary, Russian Federation, Singapore, Ukraine, Costa Rica, Czechia, G... and more
-
University Hospital, Basel, SwitzerlandETOP IBCSG Partners Foundation; Austrian Breast Cancer Study GroupActive, not recruitingNode-positive Breast CancerUnited States, Latvia, Switzerland, Hungary, Austria, Germany, South Korea, Argentina, Canada, Croatia, Greece, Italy, Lithuania
-
Relay Therapeutics, Inc.RecruitingBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Hormone Receptor Positive Tumor | PIK3CA Mutation | HER2- Negative Breast CancerUnited States, Spain, Canada, Belgium, France, Austria, Brazil, Denmark, Taiwan, Australia, Italy, Germany, Czechia, Greece, Bulgaria, Singapore, Poland, Netherlands, Portugal, South Korea, Hong Kong, Argentina
-
Gilead SciencesAlliance Foundation Trials, LLC.; NSABP Foundation Inc; GBG Forschungs GmbHRecruitingTriple Negative Breast CancerUnited States, Australia, Spain, United Kingdom, France, Germany, Belgium, Ireland, Italy, South Korea, Brazil
-
Eli Lilly and CompanyCompletedHER-2 Positive Breast Cancer | Hormone Receptor Positive Breast CancerSpain, United States, Korea, Republic of, Belgium, France, Germany, Italy, Australia, Argentina, Canada, United Kingdom, Mexico, Brazil, Greece
-
Novartis PharmaceuticalsRecruitingBreast CancerUnited States, Spain, Canada, Germany, France, Portugal, Australia, Italy, United Kingdom, China, Singapore, South Korea, Netherlands
-
Regeneron PharmaceuticalsTerminatedNon-Small Cell Lung Cancer | Triple Negative Breast Cancer | Merkel Cell Carcinoma | Basal Cell Carcinoma | Oropharynx Squamous Cell Carcinoma | Cutaneous Squamous Cell CarcinomaUnited States, Australia
-
Eli Lilly and CompanyApproved for marketingMetastatic Breast CancerSpain, Canada, Australia, Taiwan, Malaysia, United Kingdom, Italy, Switzerland, South Africa, Thailand, India, Singapore, South Korea, Egypt
-
Hoffmann-La RocheActive, not recruitingBreast CancerUnited States, Spain, Taiwan, United Kingdom, Canada, Australia, Belgium, China, France, Germany, Argentina, Poland, Mexico, Brazil, Italy, South Africa, South Korea, Turkey (Türkiye)
-
AstraZenecaCompleted
-
Jazz PharmaceuticalsRecruitingMetastatic HER2-positive Breast CancerUnited States, Austria, Italy, Spain, France, United Kingdom, Japan, Germany, Belgium, Greece, Australia, Canada, Poland, Brazil, South Korea
-
Novartis PharmaceuticalsTranslational Research in OncologyActive, not recruitingEarly Breast CancerUnited States, Canada, Italy, United Kingdom, Austria, Taiwan, Australia, Germany, Belgium, Spain, China, France, Brazil, Argentina, Hungary, Poland, Ireland, Romania, South Korea, Russia
-
MedSIRStemline Therapeutics, Inc.RecruitingAdvanced Breast Cancer | ER-positive Breast Cancer | HER2-negative Breast Cancer | ESR1 Gene MutationSpain, Austria, France, Germany, Greece, United Kingdom, Czechia, Italy, Brazil
-
Genentech, Inc.UnknownMetastatic Breast CancerAustralia, Spain, Greece, Mexico, Russian Federation, United States, Singapore, Canada, Peru, Taiwan, Korea, Republic of, Philippines, Netherlands, United Kingdom, France, Brazil, Ukraine, Sweden, Guatemala, Panama, Norway, Uruguay
-
Hoffmann-La RocheTerminatedBreast CancerItaly, United States, Korea, Republic of, Canada, Czechia, Spain, Australia, Bulgaria, China, Finland, France, Greece, Poland, Portugal, Taiwan, Thailand, Turkey, Colombia, Bosnia and Herzegovina, Mexico, Peru, Romania, Russian Federation and more
-
Daiichi SankyoAstraZeneca; Daiichi Sankyo Co., Ltd.CompletedBreast CancerUnited States, Spain, Israel, Belgium, Australia, Czechia, Italy, Japan, France, United Kingdom, Greece, Germany, Brazil, South Korea, Turkey (Türkiye)
-
GlaxoSmithKlineActive, not recruitingNeoplasms, BreastUnited States, Netherlands, Finland, Italy, Spain, Israel, Poland, Romania, Belgium, Canada, Portugal, United Kingdom, Ireland, Australia, Germany, Japan, Austria, Russian Federation, South Africa, Norway, Switzerland, France, Hungary, Braz... and more
-
Advanced Accelerator ApplicationsTerminatedBreast Cancer | Small Cell Lung Cancer | Colorectal Cancer | Prostate Cancer | Non Small Cell Lung CancerAustria, France
-
Daiichi SankyoAstraZenecaRecruitingBreast CancerUnited States, Spain, China, Belgium, Netherlands, Italy, Portugal, Ireland, Australia, Brazil
-
Bristol-Myers SquibbRecruitingBreast Cancer | Lung CancerCanada, Australia, United States, Spain, France, Italy, United Kingdom, Netherlands, Chile
-
Hospital Universitari de BellvitgeRecruitingBreast Cancer | Chemotherapy | Sentinel Lymph Node | Radiotherapy Side Effect | Axillary Lymph Nodes DissectionSpain, Australia
-
Alliance Foundation Trials, LLC.Pfizer; Syneos Health; UNICANCER; SOLTI Breast Cancer Research Group; PrECOG, LLC.; Fondazione Michelangelo and other collaboratorsActive, not recruitingHER-2 Positive Breast Cancer | Estrogen Receptor Positive Breast CancerUnited States, Spain, France, Italy, Germany, Australia, Portugal, New Zealand
-
DualityBio Inc.BioNTech SEActive, not recruitingMetastatic Breast CancerUnited States, Argentina, Australia, Canada, China, France, Germany, Hong Kong, Hungary, Israel, Poland, South Korea, Spain, Turkey (Türkiye), United Kingdom, Belgium, Italy
-
Karolinska University HospitalGerman Breast Group; Austrian Breast & Colorectal Cancer Study Group; Swedish...Active, not recruitingBreast CancerSweden, Germany, Austria
-
Alterome Therapeutics, Inc.Active, not recruitingCancer | Breast Cancer | Metastatic Cancer | Advanced Solid Tumor | Endometrial CancerUnited States, Spain, Taiwan, United Kingdom, Japan, Australia, France, South Korea
-
Novartis PharmaceuticalsCompletedMetastatic Colorectal Cancer | Gastric Cancer | Advanced Solid Tumors | Metastatic Breast Cancer | Gastroesophageal Junction Cancer | Recurrent Glioblastoma Multiforme | Advanced Pancreatic Adenocarcinoma | Safety | Triple Negative Metastatic Breast Cancer | Dose Escalation | Preliminary Efficacy | Hormone Receptor...Canada, United Kingdom, Spain, Germany, Italy, Belgium, Australia, United States